Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders

HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenous...

Full description

Saved in:
Bibliographic Details
Published inNeurobiology of disease Vol. 55; pp. 110 - 119
Main Authors Zucchini, Silvia, Pittaluga, Anna, Brocca-Cofano, Egidio, Summa, Maria, Fabris, Marina, De Michele, Rita, Bonaccorsi, Angela, Busatto, Graziella, Barbanti-Brodano, Giuseppe, Altavilla, Giuseppe, Verlengia, Gianluca, Cifelli, Pierangelo, Corallini, Alfredo, Caputo, Antonella, Simonato, Michele
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.07.2013
Elsevier
Subjects
Online AccessGet full text
ISSN0969-9961
1095-953X
1095-953X
DOI10.1016/j.nbd.2013.02.004

Cover

Abstract HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND. ► The pathogenesis of HIV-1 associated neurocognitive disorders (HAND) is unclear. ► Neurochemistry and susceptibility to seizures were studied in tat transgenic mice. ► Data suggest that tat expression in the brain causes a latent hyper-excitability state. ► Tat-induced hyper-excitability may play a key role in HAND development.
AbstractList HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.
HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.
HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat-transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND. ► The pathogenesis of HIV-1 associated neurocognitive disorders (HAND) is unclear. ► Neurochemistry and susceptibility to seizures were studied in tat transgenic mice. ► Data suggest that tat expression in the brain causes a latent hyper-excitability state. ► Tat-induced hyper-excitability may play a key role in HAND development.
Abstract HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood but, based on in vitro studies, the HIV-1 Tat protein may play an important role. In this study, the effect of prolonged exposure to endogenously produced Tat in the brain was investigated using a tat -transgenic (TT) mouse model constitutively expressing the HIV-1 tat gene. We found that stimulus-evoked glutamate exocytosis in the hippocampus and cortex was significantly increased in TT as compared with wild-type control (CC) mice, while GABA exocytosis was unchanged in the hippocampus and decreased in the cortex. This suggests that Tat generates a latent hyper-excitability state, which favors the detrimental effects of neurotoxic and/or excitotoxic agents. To challenge this idea, TT mice were tested for susceptibility to kainate-induced seizures and neurodegeneration, and found to exhibit significantly greater responses to the convulsant agent than CC mice. These results support the concept that constitutive expression of tat in the brain generates a latent excitatory state, which may increase the negative effects of damaging insults. These events may play a key role in the development of HAND.
Author Cifelli, Pierangelo
Pittaluga, Anna
Caputo, Antonella
Brocca-Cofano, Egidio
Fabris, Marina
Altavilla, Giuseppe
Simonato, Michele
Busatto, Graziella
Zucchini, Silvia
Summa, Maria
Bonaccorsi, Angela
Barbanti-Brodano, Giuseppe
Verlengia, Gianluca
Corallini, Alfredo
De Michele, Rita
Author_xml – sequence: 1
  givenname: Silvia
  surname: Zucchini
  fullname: Zucchini, Silvia
  email: silvia.zucchini@unife.it
  organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy
– sequence: 2
  givenname: Anna
  surname: Pittaluga
  fullname: Pittaluga, Anna
  organization: Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, Italy
– sequence: 3
  givenname: Egidio
  surname: Brocca-Cofano
  fullname: Brocca-Cofano, Egidio
  organization: Department of Molecular Medicine, University of Padua, Italy
– sequence: 4
  givenname: Maria
  surname: Summa
  fullname: Summa, Maria
  organization: Department of Pharmacy, Section of Pharmacology and Toxicology, University of Genoa, Italy
– sequence: 5
  givenname: Marina
  surname: Fabris
  fullname: Fabris, Marina
  organization: Department of Molecular Medicine, University of Padua, Italy
– sequence: 6
  givenname: Rita
  surname: De Michele
  fullname: De Michele, Rita
  organization: Department of Molecular Medicine, University of Padua, Italy
– sequence: 7
  givenname: Angela
  surname: Bonaccorsi
  fullname: Bonaccorsi, Angela
  organization: Department of Molecular Medicine, University of Padua, Italy
– sequence: 8
  givenname: Graziella
  surname: Busatto
  fullname: Busatto, Graziella
  organization: Department of Medicine, University of Padua, Italy
– sequence: 9
  givenname: Giuseppe
  surname: Barbanti-Brodano
  fullname: Barbanti-Brodano, Giuseppe
  organization: Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Italy
– sequence: 10
  givenname: Giuseppe
  surname: Altavilla
  fullname: Altavilla, Giuseppe
  organization: Department of Medicine, University of Padua, Italy
– sequence: 11
  givenname: Gianluca
  surname: Verlengia
  fullname: Verlengia, Gianluca
  organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy
– sequence: 12
  givenname: Pierangelo
  surname: Cifelli
  fullname: Cifelli, Pierangelo
  organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy
– sequence: 13
  givenname: Alfredo
  surname: Corallini
  fullname: Corallini, Alfredo
  organization: Department of Experimental and Diagnostic Medicine, Section of Microbiology, University of Ferrara, Italy
– sequence: 14
  givenname: Antonella
  surname: Caputo
  fullname: Caputo, Antonella
  organization: Department of Molecular Medicine, University of Padua, Italy
– sequence: 15
  givenname: Michele
  surname: Simonato
  fullname: Simonato, Michele
  organization: Department of Medical Sciences, Neuroscience Center, University of Ferrara, National Institute of Neuroscience, Italy
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23454193$$D View this record in MEDLINE/PubMed
BookMark eNqFkl1rFDEUhoNU7Hb1B3gjc-nNrCeTzEcUBClqFwqCX3gXzyRnlqyzSU1mxf33ZtzWi4LtVUjyPm9CnpyxEx88MfaUw4oDb15sV763qwq4WEG1ApAP2IKDqktVi28nbAGqUaVSDT9lZyltATivVfuInVZC1pIrsWDf195EwkS2oN_GTdi70U2HwvliwqmcIvq0Ie9MsXOGXhYfw0hFGObNOXOx_lpGGnHKvKd9DGPYOINjYV0K0VJMj9nDAcdET67HJfvy7u3n84vy8sP79fmby9I0AFPZ2LrrG0QrgEvsmsa0zSCHCvuuRZTCymrIs6ETwiqLleKy6S3UOJiqp64SS7Y-9tqAW30V3Q7jQQd0-u9CiBuNcXJmJF1bC6h4Z1UrpRpahTigAlkjdKLhInc9P3ZdxfBzT2nSO5cMjSN6CvukeQ3QdnWnuvujQqoWZFvNN3x2Hd33O7L_7ngjIwfaY8DEkFKkQc9CJhd81uBGzUHP2vVWZ-161q6h0ll7Jvkt8qb8LubVkaFs5ZejqJNx5A1ZF8lM-dncnfTrW7QZnZ_V_6ADpW3YR591a65TBvSn-SvOP5ELAGjyIy-Z-n_BPYf_AUEr69s
CitedBy_id crossref_primary_10_1007_s11481_016_9664_y
crossref_primary_10_3390_microorganisms9122537
crossref_primary_10_1007_s11481_013_9518_9
crossref_primary_10_1096_fj_202101722R
crossref_primary_10_1007_s12035_024_04113_8
crossref_primary_10_1016_j_neuropharm_2018_08_013
crossref_primary_10_1016_j_neulet_2021_135877
crossref_primary_10_1371_journal_pone_0305868
crossref_primary_10_1371_journal_ppat_1008249
crossref_primary_10_1007_s12035_019_1511_8
crossref_primary_10_1016_j_bbi_2023_07_021
crossref_primary_10_1007_s00018_021_03785_y
crossref_primary_10_3389_fcimb_2020_00261
crossref_primary_10_3389_fnmol_2017_00163
crossref_primary_10_3389_fnmol_2022_870868
crossref_primary_10_1098_rsob_200286
crossref_primary_10_1016_j_bpsc_2017_04_002
crossref_primary_10_3390_brainsci7040038
crossref_primary_10_3389_fimmu_2017_01079
crossref_primary_10_1124_jpet_124_002272
crossref_primary_10_1016_j_ijdevneu_2017_10_009
crossref_primary_10_3389_fnins_2016_00497
crossref_primary_10_1002_glia_24033
crossref_primary_10_1038_s41598_019_44463_1
crossref_primary_10_1007_s10495_014_1003_2
crossref_primary_10_3389_fnins_2018_00921
crossref_primary_10_3390_cells11193035
crossref_primary_10_3389_fnmol_2018_00324
crossref_primary_10_3389_fphar_2016_00295
crossref_primary_10_3390_ijms21103631
crossref_primary_10_1016_j_nbd_2017_04_015
Cites_doi 10.1073/pnas.95.22.13153
10.1002/ana.410330604
10.1016/S0197-0186(96)00129-5
10.1182/blood.V93.6.1851.406k12_1851_1857
10.1002/glia.20708
10.1016/j.biopsych.2006.08.003
10.1097/00001756-200211150-00016
10.1126/science.285.5433.1569
10.1124/jpet.108.150144
10.1016/j.neulet.2010.09.019
10.1038/sj.cdd.4401623
10.1523/JNEUROSCI.1472-08.2008
10.1016/S0002-9440(10)65375-8
10.1523/JNEUROSCI.23-17-06810.2003
10.1046/j.1471-4159.2001.00396.x
10.1023/B:NERE.0000021241.90133.89
10.1016/j.jneuroim.2009.09.014
10.1016/0028-3908(92)90085-4
10.1016/j.brainres.2004.03.037
10.1093/cercor/bhp274
10.1128/JVI.65.2.961-967.1991
10.1073/pnas.0611699104
10.1016/j.micinf.2005.11.014
10.1016/S0022-510X(02)00155-7
10.1016/S0006-8993(00)02513-0
10.1097/00005072-199806000-00004
10.1038/375497a0
10.1016/j.neuroscience.2007.11.031
10.1016/S0304-3940(01)01786-4
10.1016/j.neuropharm.2007.04.006
10.1046/j.1471-4159.2003.01775.x
10.1016/S0301-0082(97)00053-1
10.1523/JNEUROSCI.22-22-10030.2002
10.1016/0006-8993(86)91464-2
10.1111/j.1750-3639.1999.tb00219.x
10.1046/j.1471-4159.1999.0731363.x
10.1128/JVI.67.1.277-287.1993
10.1016/0092-8674(88)90263-2
10.1111/j.1471-4159.2011.07223.x
10.1016/j.ncl.2009.09.018
10.1006/bbrc.1999.1894
10.1007/s11481-010-9205-z
10.1124/jpet.105.099630
10.1006/exnr.2002.8048
10.1016/S0306-4522(97)00174-7
10.1016/S0002-9440(10)64304-0
10.1002/ana.410190602
10.1097/00002030-199712000-00006
10.1001/archneur.56.1.111
10.1016/j.neuroscience.2009.01.024
10.1523/JNEUROSCI.3019-08.2008
10.1002/ana.410320304
10.1016/j.virol.2007.02.004
10.1016/S1525-0016(03)00122-9
10.1016/j.nbd.2011.10.005
10.3109/13550280009013158
10.1074/jbc.275.6.4159
10.1073/pnas.0810710106
10.1023/A:1007648229795
10.1016/S0006-8993(02)03360-7
10.1016/0003-2697(76)90527-3
10.1002/jnr.21446
10.1126/science.2990040
10.1523/JNEUROSCI.18-06-02004.1998
10.1126/science.2148832
10.1016/S0140-6736(06)68075-6
ContentType Journal Article
Copyright 2013 Elsevier Inc.
Elsevier Inc.
Copyright © 2013 Elsevier Inc. All rights reserved.
Copyright_xml – notice: 2013 Elsevier Inc.
– notice: Elsevier Inc.
– notice: Copyright © 2013 Elsevier Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
8FD
FR3
P64
RC3
DOA
DOI 10.1016/j.nbd.2013.02.004
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Genetics Abstracts
Engineering Research Database
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
DatabaseTitleList MEDLINE - Academic
Genetics Abstracts



MEDLINE

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1095-953X
EndPage 119
ExternalDocumentID oai_doaj_org_article_5dd0a918d97449f79aafa9045a083613
23454193
10_1016_j_nbd_2013_02_004
S0969996113000661
1_s2_0_S0969996113000661
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.1-
.55
.FO
.GJ
.~1
0R~
123
1B1
1P~
1~.
1~5
29N
4.4
457
4G.
53G
5RE
5VS
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXLA
AAXUO
AAYWO
ABBQC
ABCQJ
ABFNM
ABFRF
ABJNI
ABMAC
ABMZM
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFGL
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGHFR
AGQPQ
AGUBO
AGWIK
AGYEJ
AIEXJ
AIGII
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
G-Q
GBLVA
GROUPED_DOAJ
HVGLF
HZ~
IHE
J1W
K-O
KOM
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OK1
OP~
OZT
P-8
P-9
P2P
PC.
Q38
R2-
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SEW
SSH
SSN
SSZ
T5K
X7M
XPP
Z5R
ZGI
ZMT
ZU3
~G-
0SF
6I.
AACTN
AFCTW
AFKWA
AJOXV
AMFUW
NCXOZ
PKN
RIG
AADPK
AAIAV
ABLVK
ABYKQ
AHPSJ
AJBFU
EFLBG
LCYCR
AAYXX
AGRNS
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
8FD
FR3
P64
RC3
ID FETCH-LOGICAL-c600t-6d58b6aad3014a866c76f4f2ab87aa43d42ff2af833d9da29146bd05afc2be823
IEDL.DBID AIKHN
ISSN 0969-9961
1095-953X
IngestDate Wed Aug 27 00:58:35 EDT 2025
Fri Sep 05 14:31:35 EDT 2025
Thu Sep 04 22:09:31 EDT 2025
Thu Apr 03 06:54:55 EDT 2025
Tue Jul 01 03:07:21 EDT 2025
Thu Apr 24 23:11:58 EDT 2025
Fri Feb 23 02:29:35 EST 2024
Sun Feb 23 10:19:13 EST 2025
Tue Aug 26 16:32:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords HIV-1 associated neurocognitive disorders
Kainate
Neurodegeneration
HIV-1-tat-transgenic mice
Seizures
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
Copyright © 2013 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-6d58b6aad3014a866c76f4f2ab87aa43d42ff2af833d9da29146bd05afc2be823
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://doaj.org/article/5dd0a918d97449f79aafa9045a083613
PMID 23454193
PQID 1349704722
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_5dd0a918d97449f79aafa9045a083613
proquest_miscellaneous_1500785898
proquest_miscellaneous_1349704722
pubmed_primary_23454193
crossref_citationtrail_10_1016_j_nbd_2013_02_004
crossref_primary_10_1016_j_nbd_2013_02_004
elsevier_sciencedirect_doi_10_1016_j_nbd_2013_02_004
elsevier_clinicalkeyesjournals_1_s2_0_S0969996113000661
elsevier_clinicalkey_doi_10_1016_j_nbd_2013_02_004
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-07-01
PublicationDateYYYYMMDD 2013-07-01
PublicationDate_xml – month: 07
  year: 2013
  text: 2013-07-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Neurobiology of disease
PublicationTitleAlternate Neurobiol Dis
PublicationYear 2013
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Bonanno, Raiteri (bb0045) 1993; 262
King (bb0205) 2006; 8
Zucchini (bb0365) 2008; 49
Li (bb0210) 2008; 28
Schwarze (bb0315) 1999; 285
Flora (bb0135) 2003; 179
Eugenin (bb0100) 2003; 85
Frankel, Pabo (bb0140) 1988; 55
Modi (bb0245) 2002; 202
Gavriil (bb0145) 2000; 267
Mengozzi (bb0235) 1999; 93
Sabatier (bb0305) 1991; 65
Virgili (bb0335) 1992; 5
Luccini (bb0225) 2007; 85
Zhu (bb0355) 2009; 329
Eugenin (bb0105) 2007; 104
Raiteri, Raiteri (bb0300) 2000; 25
Tattevin (bb0330) 2006; 367
Singer (bb0325) 2010; 28
Zucchini (bb0360) 2002; 13
Behnisch (bb0040) 2004; 1012
Bruce-Keller (bb0065) 2008; 56
Musante (bb0250) 2010; 20
Haughey (bb0170) 1999; 73
Navia, Jordan, Price (bb0270) 1986; 19
Brailoiu (bb0055) 2008; 151
Muzzolini (bb0260) 1997; 31
Peng (bb0285) 2010; 218
Bradford (bb0050) 1976; 72
Ferrari (bb0125) 2003; 8
Agrawal (bb0020) 2012; 45
Westendorp (bb0345) 1995; 375
Jones (bb0190) 1998; 57
Wessenligh (bb0340) 1993; 33
Kaul (bb0195) 2005; 12
Pittaluga (bb0290) 2007; 53
Gupta (bb0165) 2010; 485
Schmued, Hopkins (bb0310) 2000; 874
Bartolomei (bb0035) 1999; 56
Nath, Geiger (bb0265) 1998; 54
Musante (bb0255) 2011; 117
Feligioni (bb0120) 2003; 23
Minghetti (bb0240) 2004; 29
Aksenov (bb0010) 2001; 305
Selnes (bb0320) 2005; 15
Paxinos, Franklin (bb0280) 2001
Agrawal (bb0015) 2007; 363
Cheng (bb0075) 1998; 82
Fadda (bb0115) 2007; 62
Kim (bb0200) 2003; 162
Hudson (bb0180) 2000; 6
Paradiso (bb0275) 2009; 106
Haughey (bb0175) 2001; 78
Janumpalli (bb0185) 1998; 18
Lindl (bb0215) 2010; 5
Arya (bb0030) 1985; 229
Longordo (bb0220) 2006; 317
Dore (bb0085) 1996; 1
Giulian (bb0150) 1990; 250
Albini (bb0005) 1998; 95
Prendergast (bb0295) 2002; 954
Altavilla (bb0025) 1999; 154
Chang (bb0070) 1997; 12
Dunkley (bb0090) 1986; 372
Ensoli (bb0095) 1993; 67
Corallini (bb0080) 1993; 53
Masliah (bb0230) 1992; 32
Everall (bb0110) 1999; 9
Bregola (bb0060) 2002; 22
Zauli (bb0350) 2000; 275
Ferris (bb0130) 2009; 159
Ferris (10.1016/j.nbd.2013.02.004_bb0130) 2009; 159
Dunkley (10.1016/j.nbd.2013.02.004_bb0090) 1986; 372
Gavriil (10.1016/j.nbd.2013.02.004_bb0145) 2000; 267
King (10.1016/j.nbd.2013.02.004_bb0205) 2006; 8
Navia (10.1016/j.nbd.2013.02.004_bb0270) 1986; 19
Agrawal (10.1016/j.nbd.2013.02.004_bb0020) 2012; 45
Paxinos (10.1016/j.nbd.2013.02.004_bb0280) 2001
Westendorp (10.1016/j.nbd.2013.02.004_bb0345) 1995; 375
Nath (10.1016/j.nbd.2013.02.004_bb0265) 1998; 54
Zauli (10.1016/j.nbd.2013.02.004_bb0350) 2000; 275
Albini (10.1016/j.nbd.2013.02.004_bb0005) 1998; 95
Bartolomei (10.1016/j.nbd.2013.02.004_bb0035) 1999; 56
Tattevin (10.1016/j.nbd.2013.02.004_bb0330) 2006; 367
Corallini (10.1016/j.nbd.2013.02.004_bb0080) 1993; 53
Bregola (10.1016/j.nbd.2013.02.004_bb0060) 2002; 22
Janumpalli (10.1016/j.nbd.2013.02.004_bb0185) 1998; 18
Minghetti (10.1016/j.nbd.2013.02.004_bb0240) 2004; 29
Luccini (10.1016/j.nbd.2013.02.004_bb0225) 2007; 85
Flora (10.1016/j.nbd.2013.02.004_bb0135) 2003; 179
Longordo (10.1016/j.nbd.2013.02.004_bb0220) 2006; 317
Aksenov (10.1016/j.nbd.2013.02.004_bb0010) 2001; 305
Ensoli (10.1016/j.nbd.2013.02.004_bb0095) 1993; 67
Feligioni (10.1016/j.nbd.2013.02.004_bb0120) 2003; 23
Bruce-Keller (10.1016/j.nbd.2013.02.004_bb0065) 2008; 56
Schwarze (10.1016/j.nbd.2013.02.004_bb0315) 1999; 285
Brailoiu (10.1016/j.nbd.2013.02.004_bb0055) 2008; 151
Prendergast (10.1016/j.nbd.2013.02.004_bb0295) 2002; 954
Zhu (10.1016/j.nbd.2013.02.004_bb0355) 2009; 329
Mengozzi (10.1016/j.nbd.2013.02.004_bb0235) 1999; 93
Eugenin (10.1016/j.nbd.2013.02.004_bb0100) 2003; 85
Hudson (10.1016/j.nbd.2013.02.004_bb0180) 2000; 6
Dore (10.1016/j.nbd.2013.02.004_bb0085) 1996; 1
Selnes (10.1016/j.nbd.2013.02.004_bb0320) 2005; 15
Kaul (10.1016/j.nbd.2013.02.004_bb0195) 2005; 12
Frankel (10.1016/j.nbd.2013.02.004_bb0140) 1988; 55
Cheng (10.1016/j.nbd.2013.02.004_bb0075) 1998; 82
Masliah (10.1016/j.nbd.2013.02.004_bb0230) 1992; 32
Li (10.1016/j.nbd.2013.02.004_bb0210) 2008; 28
Paradiso (10.1016/j.nbd.2013.02.004_bb0275) 2009; 106
Raiteri (10.1016/j.nbd.2013.02.004_bb0300) 2000; 25
Fadda (10.1016/j.nbd.2013.02.004_bb0115) 2007; 62
Zucchini (10.1016/j.nbd.2013.02.004_bb0365) 2008; 49
Ferrari (10.1016/j.nbd.2013.02.004_bb0125) 2003; 8
Bradford (10.1016/j.nbd.2013.02.004_bb0050) 1976; 72
Bonanno (10.1016/j.nbd.2013.02.004_bb0045) 1993; 262
Lindl (10.1016/j.nbd.2013.02.004_bb0215) 2010; 5
Arya (10.1016/j.nbd.2013.02.004_bb0030) 1985; 229
Haughey (10.1016/j.nbd.2013.02.004_bb0170) 1999; 73
Eugenin (10.1016/j.nbd.2013.02.004_bb0105) 2007; 104
Agrawal (10.1016/j.nbd.2013.02.004_bb0015) 2007; 363
Jones (10.1016/j.nbd.2013.02.004_bb0190) 1998; 57
Haughey (10.1016/j.nbd.2013.02.004_bb0175) 2001; 78
Pittaluga (10.1016/j.nbd.2013.02.004_bb0290) 2007; 53
Wessenligh (10.1016/j.nbd.2013.02.004_bb0340) 1993; 33
Behnisch (10.1016/j.nbd.2013.02.004_bb0040) 2004; 1012
Modi (10.1016/j.nbd.2013.02.004_bb0245) 2002; 202
Gupta (10.1016/j.nbd.2013.02.004_bb0165) 2010; 485
Peng (10.1016/j.nbd.2013.02.004_bb0285) 2010; 218
Singer (10.1016/j.nbd.2013.02.004_bb0325) 2010; 28
Sabatier (10.1016/j.nbd.2013.02.004_bb0305) 1991; 65
Musante (10.1016/j.nbd.2013.02.004_bb0250) 2010; 20
Zucchini (10.1016/j.nbd.2013.02.004_bb0360) 2002; 13
Altavilla (10.1016/j.nbd.2013.02.004_bb0025) 1999; 154
Everall (10.1016/j.nbd.2013.02.004_bb0110) 1999; 9
Virgili (10.1016/j.nbd.2013.02.004_bb0335) 1992; 5
Muzzolini (10.1016/j.nbd.2013.02.004_bb0260) 1997; 31
Chang (10.1016/j.nbd.2013.02.004_bb0070) 1997; 12
Kim (10.1016/j.nbd.2013.02.004_bb0200) 2003; 162
Musante (10.1016/j.nbd.2013.02.004_bb0255) 2011; 117
Giulian (10.1016/j.nbd.2013.02.004_bb0150) 1990; 250
Schmued (10.1016/j.nbd.2013.02.004_bb0310) 2000; 874
References_xml – volume: 45
  start-page: 657
  year: 2012
  end-page: 670
  ident: bb0020
  article-title: HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes
  publication-title: Neurobiol. Dis.
– volume: 56
  start-page: 1414
  year: 2008
  end-page: 1427
  ident: bb0065
  article-title: Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice
  publication-title: Glia
– volume: 372
  start-page: 115
  year: 1986
  end-page: 129
  ident: bb0090
  article-title: A rapid method for isolation of synaptosomes on Percoll gradient
  publication-title: Brain Res.
– volume: 104
  start-page: 3434
  year: 2007
  end-page: 3438
  ident: bb0105
  article-title: HIV-tat induces formation of an LRP–PSD-95–NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 54
  start-page: 19
  year: 1998
  end-page: 33
  ident: bb0265
  article-title: Neurobiological aspects of HIV infections: neurotoxic mechanisms
  publication-title: Prog. Neurobiol.
– volume: 55
  start-page: 1189
  year: 1988
  end-page: 1193
  ident: bb0140
  article-title: Cellular uptake of the Tat protein from human immunodeficiency virus
  publication-title: Cell
– volume: 65
  start-page: 961
  year: 1991
  end-page: 967
  ident: bb0305
  article-title: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1
  publication-title: J. Virol.
– volume: 56
  start-page: 111
  year: 1999
  end-page: 114
  ident: bb0035
  article-title: Isolated, chronic, epilepsia partialis continua in an HIV-infected patient
  publication-title: Arch. Neurol.
– volume: 22
  start-page: 10030
  year: 2002
  end-page: 10038
  ident: bb0060
  article-title: Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures
  publication-title: J. Neurosci.
– volume: 5
  start-page: 469
  year: 1992
  end-page: 474
  ident: bb0335
  article-title: Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers
  publication-title: Neuropharmacology
– volume: 13
  start-page: 2071
  year: 2002
  end-page: 2074
  ident: bb0360
  article-title: Neuroprotective activity of CHF3381, a putative N-methyl-
  publication-title: NeuroReport
– volume: 72
  start-page: 248
  year: 1976
  end-page: 254
  ident: bb0050
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding
  publication-title: Anal. Biochem.
– volume: 82
  start-page: 97
  year: 1998
  end-page: 106
  ident: bb0075
  article-title: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein
  publication-title: Neuroscience
– volume: 23
  start-page: 6810
  year: 2003
  end-page: 6818
  ident: bb0120
  article-title: The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms
  publication-title: J. Neurosci.
– volume: 367
  start-page: 368
  year: 2006
  ident: bb0330
  article-title: Confusion, memory disorders, and ophthalmoparesis in a patient with AIDS
  publication-title: Lancet
– volume: 250
  start-page: 1593
  year: 1990
  end-page: 1596
  ident: bb0150
  article-title: Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
  publication-title: Science
– volume: 29
  start-page: 965
  year: 2004
  end-page: 978
  ident: bb0240
  article-title: Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions
  publication-title: Neurochem. Res.
– volume: 28
  start-page: 253
  year: 2010
  end-page: 275
  ident: bb0325
  article-title: Neurological presentation of AIDS
  publication-title: Neurol. Clin.
– volume: 85
  start-page: 3657
  year: 2007
  end-page: 3665
  ident: bb0225
  article-title: N-methyl-
  publication-title: J. Neurosci. Res.
– volume: 1
  start-page: 59
  year: 1996
  end-page: 69
  ident: bb0085
  article-title: Prospective analysis of seizure occurring in human immunodeficiency virus type-1 infection
  publication-title: J. NeuroAIDS
– volume: 285
  start-page: 1569
  year: 1999
  end-page: 1572
  ident: bb0315
  article-title: In vivo protein transduction: delivery of a biologically active protein into the mouse
  publication-title: Science
– volume: 485
  start-page: 233
  year: 2010
  end-page: 236
  ident: bb0165
  article-title: HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter
  publication-title: Neurosci. Lett.
– volume: 53
  start-page: 27
  year: 2007
  end-page: 36
  ident: bb0290
  article-title: Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus
  publication-title: Neuropharmacology
– volume: 375
  start-page: 497
  year: 1995
  end-page: 500
  ident: bb0345
  article-title: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
  publication-title: Nature
– volume: 15
  start-page: 289
  year: 2005
  end-page: 292
  ident: bb0320
  article-title: Memory loss in persons with HIV/AIDS: assessment and strategies for coping
  publication-title: AIDS Read.
– volume: 85
  start-page: 1299
  year: 2003
  end-page: 1311
  ident: bb0100
  article-title: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis
  publication-title: J. Neurochem.
– volume: 67
  start-page: 277
  year: 1993
  end-page: 287
  ident: bb0095
  article-title: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation
  publication-title: J. Virol.
– volume: 229
  start-page: 69
  year: 1985
  end-page: 73
  ident: bb0030
  article-title: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III)
  publication-title: Science
– volume: 218
  start-page: 94
  year: 2010
  end-page: 101
  ident: bb0285
  article-title: The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART
  publication-title: J. Neuroimmunol.
– volume: 262
  start-page: 114
  year: 1993
  end-page: 118
  ident: bb0045
  article-title: Functional evidence for multiple GABAB receptor subtypes in the rat cerebral cortex
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 25
  start-page: 1265
  year: 2000
  end-page: 1274
  ident: bb0300
  article-title: Synaptosomes still viable after 25
  publication-title: Neurochem. Res.
– volume: 12
  start-page: 1421
  year: 1997
  end-page: 1431
  ident: bb0070
  article-title: HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
  publication-title: AIDS
– volume: 31
  start-page: 113
  year: 1997
  end-page: 124
  ident: bb0260
  article-title: Characterization of glutamate and [3H]
  publication-title: Neurochem. Int.
– volume: 19
  start-page: 517
  year: 1986
  end-page: 524
  ident: bb0270
  article-title: The AIDS dementia complex: I. Clinical features
  publication-title: Ann. Neurol.
– volume: 954
  start-page: 300
  year: 2002
  end-page: 307
  ident: bb0295
  article-title: Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-
  publication-title: Brain Res.
– volume: 78
  start-page: 457
  year: 2001
  end-page: 467
  ident: bb0175
  article-title: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity
  publication-title: J. Neurochem.
– volume: 57
  start-page: 563
  year: 1998
  end-page: 570
  ident: bb0190
  article-title: Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement
  publication-title: J. Neuropathol. Exp. Neurol.
– volume: 49
  start-page: 13112
  year: 2008
  end-page: 13124
  ident: bb0365
  article-title: FGF-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss
  publication-title: J. Neurosci.
– volume: 5
  start-page: 294
  year: 2010
  end-page: 309
  ident: bb0215
  article-title: HIV-1 associated neurocognitive disorder: pathogenesis and therapeutic opportunities
  publication-title: J. Neuroimmune Pharmacol.
– volume: 6
  start-page: 145
  year: 2000
  end-page: 155
  ident: bb0180
  article-title: Detection of human immunodeficiency virus regulatory protein Tat in CNS tissues
  publication-title: J. Neurovirol.
– volume: 95
  start-page: 13153
  year: 1998
  end-page: 13158
  ident: bb0005
  article-title: HIV-1 Tat protein mimicry of chemokines
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 73
  start-page: 1363
  year: 1999
  end-page: 1374
  ident: bb0170
  article-title: Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat
  publication-title: J. Neurochem.
– volume: 363
  start-page: 462
  year: 2007
  end-page: 472
  ident: bb0015
  article-title: Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications
  publication-title: Virology
– volume: 32
  start-page: 321
  year: 1992
  end-page: 329
  ident: bb0230
  article-title: Spectrum of human immunodeficiency virus-associated neocortical damage
  publication-title: Ann. Neurol.
– volume: 20
  start-page: 1974
  year: 2010
  end-page: 1984
  ident: bb0250
  article-title: The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings
  publication-title: Cereb. Cortex
– volume: 202
  start-page: 29
  year: 2002
  end-page: 34
  ident: bb0245
  article-title: New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis—a clinical, radiological and SPECT scan study
  publication-title: J. Neurol. Sci.
– year: 2001
  ident: bb0280
  article-title: The Mouse Brain in Stereotaxic Coordinates
– volume: 874
  start-page: 123
  year: 2000
  end-page: 130
  ident: bb0310
  article-title: Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
  publication-title: Brain Res.
– volume: 8
  start-page: 1347
  year: 2006
  end-page: 1357
  ident: bb0205
  article-title: HIV Tat and neurotoxicity
  publication-title: Microbes Infect.
– volume: 162
  start-page: 1693
  year: 2003
  end-page: 1707
  ident: bb0200
  article-title: Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline
  publication-title: Am. J. Pathol.
– volume: 159
  start-page: 1292
  year: 2009
  end-page: 1299
  ident: bb0130
  article-title: The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study
  publication-title: Neuroscience
– volume: 305
  start-page: 5
  year: 2001
  end-page: 8
  ident: bb0010
  article-title: Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum
  publication-title: Neurosci. Lett.
– volume: 53
  start-page: 5569
  year: 1993
  end-page: 5575
  ident: bb0080
  article-title: Systemic expression of HIV-1
  publication-title: Cancer Res.
– volume: 12
  start-page: 878
  year: 2005
  end-page: 892
  ident: bb0195
  article-title: HIV-1 infection and AIDS: consequences for the central nervous system
  publication-title: Cell Death Differ.
– volume: 329
  start-page: 1071
  year: 2009
  end-page: 1083
  ident: bb0355
  article-title: HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 179
  start-page: 60
  year: 2003
  end-page: 70
  ident: bb0135
  article-title: Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain
  publication-title: Exp. Neurol.
– volume: 18
  start-page: 2004
  year: 1998
  end-page: 2008
  ident: bb0185
  article-title: A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine
  publication-title: J. Neurosci.
– volume: 28
  start-page: 12190
  year: 2008
  end-page: 12198
  ident: bb0210
  article-title: NMDA receptor activation by HIV-Tat protein is clade dependent
  publication-title: J. Neurosci.
– volume: 62
  start-page: 235
  year: 2007
  end-page: 242
  ident: bb0115
  article-title: Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission
  publication-title: Biol. Psychiatry
– volume: 151
  start-page: 701
  year: 2008
  end-page: 710
  ident: bb0055
  article-title: Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons
  publication-title: Neuroscience
– volume: 317
  start-page: 1097
  year: 2006
  end-page: 1105
  ident: bb0220
  article-title: The human immunodeficiency virus-1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurons
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 93
  start-page: 1851
  year: 1999
  end-page: 1857
  ident: bb0235
  article-title: Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells
  publication-title: Blood
– volume: 33
  start-page: 576
  year: 1993
  end-page: 582
  ident: bb0340
  article-title: Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia
  publication-title: Ann. Neurol.
– volume: 106
  start-page: 7191
  year: 2009
  end-page: 7196
  ident: bb0275
  article-title: Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
– volume: 275
  start-page: 4159
  year: 2000
  end-page: 4165
  ident: bb0350
  article-title: HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells
  publication-title: J. Biol. Chem.
– volume: 117
  start-page: 516
  year: 2011
  end-page: 527
  ident: bb0255
  article-title: Presynaptic glycine GlyT1 transporter–NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg
  publication-title: J. Neurochem.
– volume: 267
  start-page: 252
  year: 2000
  end-page: 256
  ident: bb0145
  article-title: Tat mediates apoptosis in vivo in the rat central nervous system
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 8
  start-page: 284
  year: 2003
  end-page: 294
  ident: bb0125
  article-title: Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time
  publication-title: Mol. Ther.
– volume: 9
  start-page: 209
  year: 1999
  end-page: 217
  ident: bb0110
  article-title: Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder
  publication-title: Brain Pathol.
– volume: 1012
  start-page: 187
  year: 2004
  end-page: 189
  ident: bb0040
  article-title: HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region
  publication-title: Brain Res.
– volume: 154
  start-page: 1231
  year: 1999
  end-page: 1244
  ident: bb0025
  article-title: Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors, dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice
  publication-title: Am. J. Pathol.
– volume: 95
  start-page: 13153
  year: 1998
  ident: 10.1016/j.nbd.2013.02.004_bb0005
  article-title: HIV-1 Tat protein mimicry of chemokines
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.95.22.13153
– year: 2001
  ident: 10.1016/j.nbd.2013.02.004_bb0280
– volume: 33
  start-page: 576
  year: 1993
  ident: 10.1016/j.nbd.2013.02.004_bb0340
  article-title: Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410330604
– volume: 1
  start-page: 59
  year: 1996
  ident: 10.1016/j.nbd.2013.02.004_bb0085
  article-title: Prospective analysis of seizure occurring in human immunodeficiency virus type-1 infection
  publication-title: J. NeuroAIDS
– volume: 31
  start-page: 113
  year: 1997
  ident: 10.1016/j.nbd.2013.02.004_bb0260
  article-title: Characterization of glutamate and [3H]d-aspartate outflow from various in vitro preparations of the rat hippocampus
  publication-title: Neurochem. Int.
  doi: 10.1016/S0197-0186(96)00129-5
– volume: 93
  start-page: 1851
  year: 1999
  ident: 10.1016/j.nbd.2013.02.004_bb0235
  article-title: Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells
  publication-title: Blood
  doi: 10.1182/blood.V93.6.1851.406k12_1851_1857
– volume: 56
  start-page: 1414
  year: 2008
  ident: 10.1016/j.nbd.2013.02.004_bb0065
  article-title: Morphine causes rapid increases in glial activation and neuronal injury in the striatum of inducible HIV-1 Tat transgenic mice
  publication-title: Glia
  doi: 10.1002/glia.20708
– volume: 62
  start-page: 235
  year: 2007
  ident: 10.1016/j.nbd.2013.02.004_bb0115
  article-title: Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission
  publication-title: Biol. Psychiatry
  doi: 10.1016/j.biopsych.2006.08.003
– volume: 13
  start-page: 2071
  year: 2002
  ident: 10.1016/j.nbd.2013.02.004_bb0360
  article-title: Neuroprotective activity of CHF3381, a putative N-methyl-d-aspartate receptor antagonist
  publication-title: NeuroReport
  doi: 10.1097/00001756-200211150-00016
– volume: 285
  start-page: 1569
  issue: 5433
  year: 1999
  ident: 10.1016/j.nbd.2013.02.004_bb0315
  article-title: In vivo protein transduction: delivery of a biologically active protein into the mouse
  publication-title: Science
  doi: 10.1126/science.285.5433.1569
– volume: 329
  start-page: 1071
  year: 2009
  ident: 10.1016/j.nbd.2013.02.004_bb0355
  article-title: HIV-1 Tat protein-induced rapid and reversible decrease in [3H]dopamine uptake: dissociation of [3H]dopamine uptake and [3H]2beta-carbomethoxy-3-beta-(4-fluorophenyl)tropane (WIN 35,428) binding in rat striatal synaptosomes
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.108.150144
– volume: 485
  start-page: 233
  year: 2010
  ident: 10.1016/j.nbd.2013.02.004_bb0165
  article-title: HIV-Tat elicits microglial glutamate release: role of NAPDH oxidase and the cystine-glutamate antiporter
  publication-title: Neurosci. Lett.
  doi: 10.1016/j.neulet.2010.09.019
– volume: 12
  start-page: 878
  year: 2005
  ident: 10.1016/j.nbd.2013.02.004_bb0195
  article-title: HIV-1 infection and AIDS: consequences for the central nervous system
  publication-title: Cell Death Differ.
  doi: 10.1038/sj.cdd.4401623
– volume: 49
  start-page: 13112
  year: 2008
  ident: 10.1016/j.nbd.2013.02.004_bb0365
  article-title: FGF-2 overexpression increases excitability and seizure susceptibility but decreases seizure-induced cell loss
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1472-08.2008
– volume: 154
  start-page: 1231
  year: 1999
  ident: 10.1016/j.nbd.2013.02.004_bb0025
  article-title: Morphological, histochemical, immunohistochemical, and ultrastructural characterization of tumors, dysplastic and non-neoplastic lesions arising in BK virus/tat transgenic mice
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)65375-8
– volume: 23
  start-page: 6810
  year: 2003
  ident: 10.1016/j.nbd.2013.02.004_bb0120
  article-title: The human immunodeficiency virus-1 protein Tat and its discrete fragments evoke selective release of acetylcholine from human and rat cerebrocortical terminals through species-specific mechanisms
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.23-17-06810.2003
– volume: 78
  start-page: 457
  year: 2001
  ident: 10.1016/j.nbd.2013.02.004_bb0175
  article-title: HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2001.00396.x
– volume: 29
  start-page: 965
  year: 2004
  ident: 10.1016/j.nbd.2013.02.004_bb0240
  article-title: Multiple actions of the human immunodeficiency virus type-1 Tat protein on microglial cell functions
  publication-title: Neurochem. Res.
  doi: 10.1023/B:NERE.0000021241.90133.89
– volume: 218
  start-page: 94
  issue: 1–2
  year: 2010
  ident: 10.1016/j.nbd.2013.02.004_bb0285
  article-title: The HIV-1 transgenic rat as a model for HIV-1 infected individuals on HAART
  publication-title: J. Neuroimmunol.
  doi: 10.1016/j.jneuroim.2009.09.014
– volume: 5
  start-page: 469
  year: 1992
  ident: 10.1016/j.nbd.2013.02.004_bb0335
  article-title: Protection from kainic acid neuropathological syndrome by NMDA receptor antagonists: effect of MK-801 and CGP 39551 on neurotransmitter and glial markers
  publication-title: Neuropharmacology
  doi: 10.1016/0028-3908(92)90085-4
– volume: 1012
  start-page: 187
  year: 2004
  ident: 10.1016/j.nbd.2013.02.004_bb0040
  article-title: HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2004.03.037
– volume: 20
  start-page: 1974
  year: 2010
  ident: 10.1016/j.nbd.2013.02.004_bb0250
  article-title: The HIV-1 viral protein Tat increases glutamate and decreases GABA exocytosis from human and mouse neocortical nerve endings
  publication-title: Cereb. Cortex
  doi: 10.1093/cercor/bhp274
– volume: 65
  start-page: 961
  year: 1991
  ident: 10.1016/j.nbd.2013.02.004_bb0305
  article-title: Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1
  publication-title: J. Virol.
  doi: 10.1128/JVI.65.2.961-967.1991
– volume: 104
  start-page: 3434
  year: 2007
  ident: 10.1016/j.nbd.2013.02.004_bb0105
  article-title: HIV-tat induces formation of an LRP–PSD-95–NMDAR–nNOS complex that promotes apoptosis in neurons and astrocytes
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0611699104
– volume: 8
  start-page: 1347
  year: 2006
  ident: 10.1016/j.nbd.2013.02.004_bb0205
  article-title: HIV Tat and neurotoxicity
  publication-title: Microbes Infect.
  doi: 10.1016/j.micinf.2005.11.014
– volume: 202
  start-page: 29
  year: 2002
  ident: 10.1016/j.nbd.2013.02.004_bb0245
  article-title: New onset seizures in HIV-infected patients without intracranial mass lesions or meningitis—a clinical, radiological and SPECT scan study
  publication-title: J. Neurol. Sci.
  doi: 10.1016/S0022-510X(02)00155-7
– volume: 874
  start-page: 123
  year: 2000
  ident: 10.1016/j.nbd.2013.02.004_bb0310
  article-title: Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration
  publication-title: Brain Res.
  doi: 10.1016/S0006-8993(00)02513-0
– volume: 57
  start-page: 563
  issue: 6
  year: 1998
  ident: 10.1016/j.nbd.2013.02.004_bb0190
  article-title: Intraventricular injection of human immunodeficiency virus type 1 (HIV-1) tat protein causes inflammation, gliosis, apoptosis, and ventricular enlargement
  publication-title: J. Neuropathol. Exp. Neurol.
  doi: 10.1097/00005072-199806000-00004
– volume: 375
  start-page: 497
  year: 1995
  ident: 10.1016/j.nbd.2013.02.004_bb0345
  article-title: Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120
  publication-title: Nature
  doi: 10.1038/375497a0
– volume: 151
  start-page: 701
  year: 2008
  ident: 10.1016/j.nbd.2013.02.004_bb0055
  article-title: Excitatory effects of human immunodeficiency virus 1 Tat on cultured rat cerebral cortical neurons
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2007.11.031
– volume: 305
  start-page: 5
  issue: 1
  year: 2001
  ident: 10.1016/j.nbd.2013.02.004_bb0010
  article-title: Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum
  publication-title: Neurosci. Lett.
  doi: 10.1016/S0304-3940(01)01786-4
– volume: 53
  start-page: 27
  year: 2007
  ident: 10.1016/j.nbd.2013.02.004_bb0290
  article-title: Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus
  publication-title: Neuropharmacology
  doi: 10.1016/j.neuropharm.2007.04.006
– volume: 85
  start-page: 1299
  year: 2003
  ident: 10.1016/j.nbd.2013.02.004_bb0100
  article-title: MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2003.01775.x
– volume: 54
  start-page: 19
  year: 1998
  ident: 10.1016/j.nbd.2013.02.004_bb0265
  article-title: Neurobiological aspects of HIV infections: neurotoxic mechanisms
  publication-title: Prog. Neurobiol.
  doi: 10.1016/S0301-0082(97)00053-1
– volume: 22
  start-page: 10030
  year: 2002
  ident: 10.1016/j.nbd.2013.02.004_bb0060
  article-title: Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.22-22-10030.2002
– volume: 372
  start-page: 115
  year: 1986
  ident: 10.1016/j.nbd.2013.02.004_bb0090
  article-title: A rapid method for isolation of synaptosomes on Percoll gradient
  publication-title: Brain Res.
  doi: 10.1016/0006-8993(86)91464-2
– volume: 9
  start-page: 209
  year: 1999
  ident: 10.1016/j.nbd.2013.02.004_bb0110
  article-title: Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.1999.tb00219.x
– volume: 73
  start-page: 1363
  year: 1999
  ident: 10.1016/j.nbd.2013.02.004_bb0170
  article-title: Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein Tat
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.1999.0731363.x
– volume: 67
  start-page: 277
  year: 1993
  ident: 10.1016/j.nbd.2013.02.004_bb0095
  article-title: Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation
  publication-title: J. Virol.
  doi: 10.1128/JVI.67.1.277-287.1993
– volume: 262
  start-page: 114
  year: 1993
  ident: 10.1016/j.nbd.2013.02.004_bb0045
  article-title: Functional evidence for multiple GABAB receptor subtypes in the rat cerebral cortex
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 55
  start-page: 1189
  year: 1988
  ident: 10.1016/j.nbd.2013.02.004_bb0140
  article-title: Cellular uptake of the Tat protein from human immunodeficiency virus
  publication-title: Cell
  doi: 10.1016/0092-8674(88)90263-2
– volume: 117
  start-page: 516
  year: 2011
  ident: 10.1016/j.nbd.2013.02.004_bb0255
  article-title: Presynaptic glycine GlyT1 transporter–NMDA receptor interaction: relevance to NMDA autoreceptor activation in the presence of Mg2+ ions
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2011.07223.x
– volume: 28
  start-page: 253
  year: 2010
  ident: 10.1016/j.nbd.2013.02.004_bb0325
  article-title: Neurological presentation of AIDS
  publication-title: Neurol. Clin.
  doi: 10.1016/j.ncl.2009.09.018
– volume: 267
  start-page: 252
  issue: 1
  year: 2000
  ident: 10.1016/j.nbd.2013.02.004_bb0145
  article-title: Tat mediates apoptosis in vivo in the rat central nervous system
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1006/bbrc.1999.1894
– volume: 5
  start-page: 294
  year: 2010
  ident: 10.1016/j.nbd.2013.02.004_bb0215
  article-title: HIV-1 associated neurocognitive disorder: pathogenesis and therapeutic opportunities
  publication-title: J. Neuroimmune Pharmacol.
  doi: 10.1007/s11481-010-9205-z
– volume: 317
  start-page: 1097
  year: 2006
  ident: 10.1016/j.nbd.2013.02.004_bb0220
  article-title: The human immunodeficiency virus-1 protein Tat upregulates NMDA receptor function by acting at mGluR1 receptors coexisting on human and rat brain noradrenergic neurons
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.105.099630
– volume: 179
  start-page: 60
  issue: 1
  year: 2003
  ident: 10.1016/j.nbd.2013.02.004_bb0135
  article-title: Methamphetamine potentiates HIV-1 Tat protein-mediated activation of redox-sensitive pathways in discrete regions of the brain
  publication-title: Exp. Neurol.
  doi: 10.1006/exnr.2002.8048
– volume: 82
  start-page: 97
  year: 1998
  ident: 10.1016/j.nbd.2013.02.004_bb0075
  article-title: Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein
  publication-title: Neuroscience
  doi: 10.1016/S0306-4522(97)00174-7
– volume: 162
  start-page: 1693
  year: 2003
  ident: 10.1016/j.nbd.2013.02.004_bb0200
  article-title: Neuropathologies in transgenic mice expressing human immunodeficiency virus type 1 Tat protein under the regulation of the astrocyte-specific glial fibrillary acidic protein promoter and doxycycline
  publication-title: Am. J. Pathol.
  doi: 10.1016/S0002-9440(10)64304-0
– volume: 19
  start-page: 517
  year: 1986
  ident: 10.1016/j.nbd.2013.02.004_bb0270
  article-title: The AIDS dementia complex: I. Clinical features
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410190602
– volume: 12
  start-page: 1421
  year: 1997
  ident: 10.1016/j.nbd.2013.02.004_bb0070
  article-title: HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
  publication-title: AIDS
  doi: 10.1097/00002030-199712000-00006
– volume: 56
  start-page: 111
  year: 1999
  ident: 10.1016/j.nbd.2013.02.004_bb0035
  article-title: Isolated, chronic, epilepsia partialis continua in an HIV-infected patient
  publication-title: Arch. Neurol.
  doi: 10.1001/archneur.56.1.111
– volume: 159
  start-page: 1292
  year: 2009
  ident: 10.1016/j.nbd.2013.02.004_bb0130
  article-title: The human immunodeficiency virus-1-associated protein, Tat1-86, impairs dopamine transporters and interacts with cocaine to reduce nerve terminal function: a no-net-flux microdialysis study
  publication-title: Neuroscience
  doi: 10.1016/j.neuroscience.2009.01.024
– volume: 28
  start-page: 12190
  year: 2008
  ident: 10.1016/j.nbd.2013.02.004_bb0210
  article-title: NMDA receptor activation by HIV-Tat protein is clade dependent
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.3019-08.2008
– volume: 32
  start-page: 321
  year: 1992
  ident: 10.1016/j.nbd.2013.02.004_bb0230
  article-title: Spectrum of human immunodeficiency virus-associated neocortical damage
  publication-title: Ann. Neurol.
  doi: 10.1002/ana.410320304
– volume: 363
  start-page: 462
  year: 2007
  ident: 10.1016/j.nbd.2013.02.004_bb0015
  article-title: Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications
  publication-title: Virology
  doi: 10.1016/j.virol.2007.02.004
– volume: 8
  start-page: 284
  year: 2003
  ident: 10.1016/j.nbd.2013.02.004_bb0125
  article-title: Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time
  publication-title: Mol. Ther.
  doi: 10.1016/S1525-0016(03)00122-9
– volume: 45
  start-page: 657
  year: 2012
  ident: 10.1016/j.nbd.2013.02.004_bb0020
  article-title: HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes
  publication-title: Neurobiol. Dis.
  doi: 10.1016/j.nbd.2011.10.005
– volume: 6
  start-page: 145
  year: 2000
  ident: 10.1016/j.nbd.2013.02.004_bb0180
  article-title: Detection of human immunodeficiency virus regulatory protein Tat in CNS tissues
  publication-title: J. Neurovirol.
  doi: 10.3109/13550280009013158
– volume: 275
  start-page: 4159
  issue: 6
  year: 2000
  ident: 10.1016/j.nbd.2013.02.004_bb0350
  article-title: HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.275.6.4159
– volume: 106
  start-page: 7191
  year: 2009
  ident: 10.1016/j.nbd.2013.02.004_bb0275
  article-title: Localized delivery of fibroblast growth factor-2 and brain-derived neurotrophic factor reduces spontaneous seizures in an epilepsy model
  publication-title: Proc. Natl. Acad. Sci. U. S. A.
  doi: 10.1073/pnas.0810710106
– volume: 25
  start-page: 1265
  year: 2000
  ident: 10.1016/j.nbd.2013.02.004_bb0300
  article-title: Synaptosomes still viable after 25years of superfusion
  publication-title: Neurochem. Res.
  doi: 10.1023/A:1007648229795
– volume: 954
  start-page: 300
  year: 2002
  ident: 10.1016/j.nbd.2013.02.004_bb0295
  article-title: Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine sensitive-site on the N-methyl-d-aspartate receptor
  publication-title: Brain Res.
  doi: 10.1016/S0006-8993(02)03360-7
– volume: 72
  start-page: 248
  year: 1976
  ident: 10.1016/j.nbd.2013.02.004_bb0050
  article-title: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding
  publication-title: Anal. Biochem.
  doi: 10.1016/0003-2697(76)90527-3
– volume: 85
  start-page: 3657
  year: 2007
  ident: 10.1016/j.nbd.2013.02.004_bb0225
  article-title: N-methyl-d-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus
  publication-title: J. Neurosci. Res.
  doi: 10.1002/jnr.21446
– volume: 53
  start-page: 5569
  year: 1993
  ident: 10.1016/j.nbd.2013.02.004_bb0080
  article-title: Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes
  publication-title: Cancer Res.
– volume: 229
  start-page: 69
  year: 1985
  ident: 10.1016/j.nbd.2013.02.004_bb0030
  article-title: Trans-activator gene of human T-lymphotropic virus type III (HTLV-III)
  publication-title: Science
  doi: 10.1126/science.2990040
– volume: 18
  start-page: 2004
  year: 1998
  ident: 10.1016/j.nbd.2013.02.004_bb0185
  article-title: A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.18-06-02004.1998
– volume: 250
  start-page: 1593
  year: 1990
  ident: 10.1016/j.nbd.2013.02.004_bb0150
  article-title: Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1
  publication-title: Science
  doi: 10.1126/science.2148832
– volume: 15
  start-page: 289
  year: 2005
  ident: 10.1016/j.nbd.2013.02.004_bb0320
  article-title: Memory loss in persons with HIV/AIDS: assessment and strategies for coping
  publication-title: AIDS Read.
– volume: 367
  start-page: 368
  year: 2006
  ident: 10.1016/j.nbd.2013.02.004_bb0330
  article-title: Confusion, memory disorders, and ophthalmoparesis in a patient with AIDS
  publication-title: Lancet
  doi: 10.1016/S0140-6736(06)68075-6
SSID ssj0011597
Score 2.2737892
Snippet HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely understood...
Abstract HIV-1 associated neurocognitive disorders (HAND) are a major complication of HIV-1 infection. The mechanism(s) underlying HAND are not completely...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 110
SubjectTerms Analysis of Variance
Animals
Brain - drug effects
Brain - metabolism
Brain - pathology
Brain - virology
Disease Models, Animal
Dose-Response Relationship, Drug
Gene Products, tat - pharmacology
HIV-1 associated neurocognitive disorders
HIV-1-tat-transgenic mice
Human immunodeficiency virus 1
Kainate
Kainic Acid - toxicity
Male
Mice
Mice, Transgenic
Nervous System Diseases - pathology
Nervous System Diseases - virology
Neurodegeneration
Neurology
Neurotransmitter Agents - metabolism
Seizures
Seizures - chemically induced
Seizures - physiopathology
Statistics, Nonparametric
tat Gene Products, Human Immunodeficiency Virus - genetics
tat Gene Products, Human Immunodeficiency Virus - metabolism
Vesicular Glutamate Transport Proteins - metabolism
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLgpZHykOuhDggRSSOHcfcCmq1rVQOQFFvZuKHtKhkK3Yr0X_PjOOsqNRuLxx3dxyvPDOeb-LxN4y9cS20EgwmOdDT2ypTl6ZRujQRjJMxQujogvPJ53Z2Ko_P1Nk_rb6oJmykBx4X7r3yvgJTdx6BrzRRGwB8DAIRIF7l1K9WVKaakql8foBBWk9nmKmaa-iJFrRuRoJOeS0KJbL-a8HoNrCZgs7hI_Ywo0W-P_7Lx-xeGLbZzv6AmfKvK_6Wp_rN9GJ8m90_ycfkO-wHej0VmwfPwx-H2X-qgL3i84EjtixXFJ_QcOaOUzP6D_zL4jzwRaQfSWZ29L1Md1xwfOK7zPsj95mqc_mEnR4efPs0K3MrhdIholmVrVdd3wJ4yqCga1un2yijQAVpANl4KSJ-il3TeONBGNxAe18piE70oRPNU7Y1LIbwnPGISx8gxDqqXgbM1jz6tMYtv1fCgdEFq6altS7zjFO7i3M7FZT9tKgNS9qwlbCojYK9Ww-5GEk2Ngl_JH2tBYkfO32BVmOz1di7rKZgYtK2na6g4qaJD5pvmlnfNCgss9svbW2XKGm_Yl5IiWRNZ4WI6eqCyfXIjGxGxHLXhHuTIVr0ejrKgSEsLnGiRhqdiD43yCjCf6ozXcGejVa8XjTRSCURu-_-j8V8wR6I1CSEiphfsq3V78vwCqHaqn-dvPIvocM6VQ
  priority: 102
  providerName: Directory of Open Access Journals
Title Increased excitability in tat-transgenic mice: Role of tat in HIV-related neurological disorders
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0969996113000661
https://www.clinicalkey.es/playcontent/1-s2.0-S0969996113000661
https://dx.doi.org/10.1016/j.nbd.2013.02.004
https://www.ncbi.nlm.nih.gov/pubmed/23454193
https://www.proquest.com/docview/1349704722
https://www.proquest.com/docview/1500785898
https://doaj.org/article/5dd0a918d97449f79aafa9045a083613
Volume 55
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdGJyFeEGzAAqwyEuIBKbRx7CTmrauYOmATGgztzTixjYJGMq2dxF7427lznEgVUCQem57jyHe-D9_dz4Q8rzKdcS0hyNElnlbJJJapyGPptKy4c9oW2OB8fJItzvjbc3G-ReZ9LwyWVQbd3-l0r63Dk0lYzcllXU8-gvON3nqCCRkwnBACbTOw9sWIbM-O3i1OhmQCWGzfNQ30MQ7ok5u-zKspES80STvkTr5mnjyK_5qV-psX6q3R4T1yN7iRdNZ96X2yZZsdsjtrIIT-fkNfUF_Y6U_Md8jt45A_3yVfQB1gFbo11P6o6lUH0n1D64aC0xmv0HCBRNUVxVvqX9PT9sLS1uGfSLM4-hz75hcY74Ewg-KkJmB4Lh-Qs8M3n-aLONyxEFfg6qzizIiizLQ2GFrpIsuqPHPcMeBcrjVPDWcOfrkiTY00mknQrKWZCu0qVtqCpQ_JqGkbu0eo40JbbV3iRMkthHEGNnsOtqAUrNIyj8i0X1pVBQByvAfjQvWVZt8UcEMhN9SUKeBGRF4OQy479I1NxAfIr4EQgbP9g_bqqwqSo4QxUy2TwkAcxaXLpdYgleDXaoTpTtKIsJ7bqu9NBW0KL6o3zZz_aZBdBn2wVIlaAqX6TWYjwoeRa2L_rwmf9YKoQB1gjkc3tr2GiVIuc48AuoFGoGMoCllE5FEnxcOisZQLDk794__7sCfkDvP3hWA981MyWl1d233w2lblmNx69TMZw96cn77_MA57dOzPQH4BBh1BmQ
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqrQRcELQ8Ul5GQhyQot04zsPclooqS7t7gBb1ZpzYRkFtUnVTif57Zhwn0gpYJI5JZuLIM55HPP6GkDdVqlKuBCQ5qsS_VSIKRZxkobBKVNxaZXI84LxcpcUZ_3SenO-Qw-EsDJZVetvf23Rnrf2dqZ_N6VVdT79A8I3ReoQbMuA4IQXa5djUekJ254vjYjVuJoDHdqemgT5EhmFz05V5NSXihUZxj9zJN9yTQ_Hf8FJ_i0KdNzp6QO77MJLO-y99SHZMs0f25w2k0Je39C11hZ3uj_keubP0--f75BuYA6xCN5qan1Xd9SDdt7RuKASdYYeOCzSqrih2qX9PP7cXhrYWHyJNsfgausMvwO-AML3hpNpjeK4fkbOjj6eHReh7LIQVhDpdmOokL1OlNKZWKk_TKksttwwklynFY82ZhSubx7EWWjEBlrXUs0TZipUmZ_FjMmnaxjwl1PJEGWVsZJOSG0jjNCz2DHxBmbBKiSwgs2FqZeUByLEPxoUcKs1-SJCGRGnIGZMgjYC8G1muevSNbcQfUF4jIQJnuxvt9XfpNUcmWs-UiHINeRQXNhNKgVZCXKsQpjuKA8IGacvhbCpYU3hRvW3k7E9MZu3twVpGcg2U8jedDQgfOTfU_l8Dvh4UUYI5wD0e1Zj2BgaKucgcAugWmgQDwyQXeUCe9Fo8ThqLcQ2J-OD_PuwVuVucLk_kyWJ1_IzcY653CNY2PyeT7vrGvIAIritf-hX6C_8GQPU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+excitability+in+tat-transgenic+mice%3A+Role+of+tat+in+HIV-related+neurological+disorders&rft.jtitle=Neurobiology+of+disease&rft.au=Zucchini%2C+Silvia&rft.au=Pittaluga%2C+Anna&rft.au=Brocca-Cofano%2C+Egidio&rft.au=Summa%2C+Maria&rft.date=2013-07-01&rft.issn=0969-9961&rft.volume=55&rft.spage=110&rft.epage=119&rft_id=info:doi/10.1016%2Fj.nbd.2013.02.004&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_nbd_2013_02_004
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F09699961%2FS0969996113X00063%2Fcov150h.gif